Becton Dickinson (NYSE:BDX) is in talks with rivals including Thermo Fisher (TMO) and Danaher (DHR) over plans to divest its ...

Becton Dickinson & Co. closed 10.30% short of its 52-week high of $251.99, which the company reached on February 3rd.

U.S. medical device maker Becton Dickinson is in talks with Thermo Fisher and Danaher for a potential sale of its life sciences unit, the Financial Times reported on Tuesday. Becton Dickinson had in ...

Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

Plus, an all-cash takeover offer for Fortnox surprises short sellers and a creditor-on-creditor fight makes its way to Europe ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Centesis Catheters Market Worth ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's ...

In February the company had announced its plan to separate the unit, which consists of biosciences and diagnostic solutions, ...